Ulf Landmesser
← Back to Freie Universität Berlin
Freie Universität Berlin
Ulf Landmesser works in Lipoproteins and Cardiovascular Health, Coronary Interventions and Diagnostics, Cardiac Imaging and Diagnostics, Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes. Recorded institutional associations include Humboldt-Universität zu Berlin, Deutsches Herzzentrum der Charité, German Centre for Cardiovascular Research.
Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.
Selected research works
Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
2021 · 13,353 citations2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
2020 · 9,971 citations2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk
2019 · 8,976 citations2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 · 8,274 citations2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
2015 · 6,930 citations2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
2021 · 6,494 citations2023 ESC Guidelines for the management of acute coronary syndromes
2023 · 5,204 citations2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2020 · 5,029 citations2014 ESC/EACTS Guidelines on myocardial revascularization
2014 · 4,199 citationsLow-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
2017 · 3,945 citations2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 · 3,161 citations2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2022 · 3,140 citations2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
2022 · 3,076 citations2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
2017 · 2,987 citations2023 ESC Guidelines for the management of cardiomyopathies
2023 · 2,755 citations2020 ESC Guidelines for the management of adult congenital heart disease
2020 · 2,311 citations2023 ESC Guidelines for the management of endocarditis
2023 · 1,754 citationsOxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension
2003 · 1,655 citationsLow-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel
2020 · 1,591 citations2016 ESC/EAS Guidelines for the Management of Dyslipidaemias
2016 · 1,585 citationsRole of oxidative stress in atherosclerosis
2003 · 1,273 citationsPCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock
2017 · 1,205 citationsInclisiran in Patients at High Cardiovascular Risk with Elevated LDL Cholesterol
2017 · 990 citationsMapping the human genetic architecture of COVID-19
2021 · 983 citationsA Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy
2007 · 906 citations
